Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients
Clinical trial NCT00002099 · UNKNOWN
Trial details
- NCT number
- NCT00002099
- Sponsor
- AJI Pharma USA
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.